Dark

CALA
Calithera Biosciences Inc
stock NASDAQ

At Close

5/20/2022 3:59:59 PM EDT

0.2331USD+12.067%(+0.0251)2,157,348

0.2050Bid 0.2820Ask 0.0770Spread IEX

Pre-market

1969-12-31

0.00USD-100.000%(-0.21)0

After-hours

1969-12-31

0.00USD0.000%(0.00)0

Overview Option Chain HistoricalMore

open chart

Market Cap

22.666M

CEO

Susan Molineaux

Headquarters

South San Francisco, California, USA

Industry

Biotechnology

Next Earnings

2022-08-04 (74d)

ORPN PIRS CSBR ELOX XLV

Jan 31, 2022

10:29AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022 Benzinga

07:57AM EST Ladenburg Thalmann Initiates Coverage On Calithera Biosciences with Buy Rating, Announces Price Target of $4 Benzinga

Jan 20, 2022

10:41AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022 Benzinga

07:40AM EST The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.25 A.M. ET). RTTNews

06:15AM EST SVB Leerink Upgrades Calithera Biosciences to Outperform, Raises Price Target to $3 Benzinga

More News

Stats

Avg. Vol. 10 Day

6,437,928

Avg. Vol. 30 Day

5,106,803

Employees

Market Cap

22,665,752

Shares Out.

97,236,174

Float

66,847,820

On/Off Exchange

42%/58%

6 Month Beta

2.71

1 Year Beta

2.36

2 Year Beta

1.71

3 Year Beta

1.50

52 Week Low

0.15

52 Week High

2.59

SMA50

0.28

SMA200

0.58

1 Week

+8.42%

1 Month

-26.77%

3 Month

-51.00%

6 Month

-74.30%

1 Year

-88.95%

2 Year

-96.28%

5 Year

-98.59%

Profile

Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to preferentially block tumor cells and enhance immune-cell activity. Driven by a commitment to rigorous science and a passion for improving the lives of people impacted by cancer and other life-threatening diseases, Calithera is advancing a pipeline of first-in-clinic, oral therapeutics to meaningfully expand treatment options available to patients. Calithera is headquartered in South San Francisco, California.

CALA Stock Summary

Calithera Biosciences Inc (NASDAQ:CALA) stock price today is $0.2331, and today's volume is 2,157,348. CALA is up 12.067% today. The 30 day average volume is 5,106,803. CALA market cap is 22.666M with 97,236,174 shares outstanding.